Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Return to: PBR Home | Drug Research
Today in Drug Research

Drug Research

Pfizer acquires Anacor Pharmaceuticals for $5.2bn Pfizer has acquired Anacor Pharmaceuticals, which is engaged in the discovery, development and commercialization of novel small-molecule therapeutics, for $5.2bn. Drug Research > Drug Discovery & Development > News

Latest Drug Research News by Sector

Select a sector from the list or browse by sector below:

Drug Delivery

Kitov's KIT-302 drug achieves manufacturing milestone ahead of planned NDA Filing with FDA
Kitov Pharmaceuticals announced that Dexcel Pharma, Kitov's manufacturing partner, has successfully completed an initial stability study for its lead drug candidate KIT-302.
Drug Research > Drug Delivery > News
FDA approves changes to SABRIL REMS Program
Lundbeck announced that the U.S. Food and Drug Administration (FDA) approved a modified Risk Evaluation and Mitigation Strategy (REMS) for Sabril® (vigabatrin).
Drug Research > Drug Delivery > News

Drug Discovery & Development

Onxeo advances development plan for first-in-class signal interfering DNA compound AsiDNA
Onxeo announced its plan for further development of AsiDNA, its first-in-class signal interfering DNA molecule which breaks the cycle of tumor DNA repair to induce cancer cell death.
Drug Research > Drug Discovery & Development > News
Hengrui Therapeutics unveils $100m investment from HR Bio Holdings for global clinical development
Hengrui Therapeutics (HTI) has signed an agreement with HR Bio Holdings Limited, a joint venture between Jiangsu Hengrui Medicine Co. Ltd. (JHM) and an undisclosed blue chip investment firm, regarding a $100 million investment in HTI.
Drug Research > Drug Discovery & Development > News